MIGRAINE HEADACHE IN CHILDREN Suhair ShehadehSaieg M D

  • Slides: 40
Download presentation
MIGRAINE HEADACHE IN CHILDREN Suhair Shehadeh-Saieg M. D Pediatric Department Bnai-Zion Medical Center, Haifa

MIGRAINE HEADACHE IN CHILDREN Suhair Shehadeh-Saieg M. D Pediatric Department Bnai-Zion Medical Center, Haifa

Headache classification • Primary headache migraine, tension , cluster • Secondary headache Infection, trauma,

Headache classification • Primary headache migraine, tension , cluster • Secondary headache Infection, trauma, hemorrhage, tumor, high intracranial pressure.

Tension headache • Bilateral, pressing tightness • Non-throbbing, mild to moderate • Lasts from

Tension headache • Bilateral, pressing tightness • Non-throbbing, mild to moderate • Lasts from 30 minutes to several days • May be associated with photophobia or • phonophobia Is not accompanied by nausea or vomiting

Cluster headache • More apparent between ages 10 -20 y • M: F =

Cluster headache • More apparent between ages 10 -20 y • M: F = 9: 1 after age 20 y. • Always unilateral, mainly frontal-peri-orbital • Severe nature, less than three hours • Usually associated with ipsilateral autonomic findings ( lacrimation, rhinorrhea, ophthalmic injection, horner syndrome)

Migraine • Episodic, periodic, paroxysmal attacks of • • moderate to severe throbbing pain,

Migraine • Episodic, periodic, paroxysmal attacks of • • moderate to severe throbbing pain, separated by pain free intervals, Associated with nausea, vomiting, photophobia, abdominal pain and desire to sleep, motion sickness. Family history 70 -90%

Incidence of migraine • In 50% of cases : < 20 y • The

Incidence of migraine • In 50% of cases : < 20 y • The youngest age reported was 3 y • 7 y : 1 -3% • 7 -15 : 4 -11% • < 7 y >>> M>F • 7 -11 y M=F • >11 F>M

Signs and symptoms of intracranial pathology • • Sleep related headache Absence of family

Signs and symptoms of intracranial pathology • • Sleep related headache Absence of family history of migraine Vomitingabsence of visual symptoms Headache of less than six month duration Confusion Abnormal neurologic examination Growth abnormality , pulsatile tinitus Lack of response to medical therapy

pathophysiology • Vascular theory • Neuronal theory ( cortical spreading depression)

pathophysiology • Vascular theory • Neuronal theory ( cortical spreading depression)

Precipitating factors • Anxiety • Fatigue • Head trauma • Stress • Menses •

Precipitating factors • Anxiety • Fatigue • Head trauma • Stress • Menses • Illness • diet

Dietary items and chemical migraine triggers • • • Offending food items Cheese Chocolate

Dietary items and chemical migraine triggers • • • Offending food items Cheese Chocolate Hot dogs, ham, cured meats Yugort, dairy products Asian frozen snack foods Wine, beer Fasting Coffee, tea, cola Food diyes, additives • • Chemical triggers Tyramin Nitric oxide, nitrites Allergenic proteins (casein ) Monosodium glutamate Aspartame Histamine, tyramine sulfite

Pathophyiology schema Primary triger Locus ceruleus >> cortical deppretion Trigeminal nucleus Neuronal inflammation Vasodilatation

Pathophyiology schema Primary triger Locus ceruleus >> cortical deppretion Trigeminal nucleus Neuronal inflammation Vasodilatation pain vasoconstriction aura

Serotonin • Released from brainstem serotonergic nuclei. • Plays an important role in the

Serotonin • Released from brainstem serotonergic nuclei. • Plays an important role in the pathogenesis of migraine • Direct action upon the cranial vasculature • Role in central pain control pathways

Classification of migraine (revised international headache society IHS 2004) • Migraine without aura •

Classification of migraine (revised international headache society IHS 2004) • Migraine without aura • Migraine with typical aura

Migraine without aura (IHS 2004) • A. at least 5 attacks fulfilling criteria B

Migraine without aura (IHS 2004) • A. at least 5 attacks fulfilling criteria B through D. • B. Headache attacks lasting 4 to 72 h • C. headache has at least 2 of the following • • -unilateral location -pulsating quality -moderate or severe pain intensity -aggravation by or causing avoidence of routine physical activity D. during headache at least one of the folowing: nausea, vomiting, or both, photophobia, phonophobia E. not attributed to another disorder.

Migraine with aura (IHS 2004) • A. at least 2 attacks fulfilling criteria B.

Migraine with aura (IHS 2004) • A. at least 2 attacks fulfilling criteria B. • B. migraine aura fulfilling criteria B or C for one of the • following subforms: Typical aura with migraine headache Typical aura with nonmigraine pain Typical aura without headache Familial hemiplegic migraine Sporadic hemiplegic migraine Basilar type migraine C. Not attributed to another disorder.

Migraine with typical aura (IHS 2004) • A. at least 2 attacks fulfilling criteria

Migraine with typical aura (IHS 2004) • A. at least 2 attacks fulfilling criteria B or D. • B. Aura consisting at least one of the following, but no motor weakness: • • • Fully reversible visual symptoms Fully reversible sensory symptoms (numbness, pins and needles) Fully reversible dysphasia C. at least two of the following: Homonymous visual and/or unilateral sensory symptoms At least one aura symptom developes gradually over >5 minutes Each symptom lasts >5 and <60 minutes D. headache fulfilling criteria B through D for Migraine without aura begins during the aura or follows aura within 60 minutes E. not attributed to another disorder.

Familial Hemiplegic Migraine (IHS 2004) • Migraine with aura • At least one first

Familial Hemiplegic Migraine (IHS 2004) • Migraine with aura • At least one first or second degree relative who • has migraine aura that includes motor weakness. AD inheritance

Sporadic hemiplegic migraine (IHS 2004) • Migraine with an aura of motor weakness with

Sporadic hemiplegic migraine (IHS 2004) • Migraine with an aura of motor weakness with no family history

Basilar type migraine • 3 -19% of children with migraine • Average 7 y

Basilar type migraine • 3 -19% of children with migraine • Average 7 y • Occipital headache • Any combination of : vetigo, • ataxia, diplopia, tinnitus, vomiting, visual symptoms, parasthesias and altered consciousness Absence of weakness.

Childhood periodic syndromes ( precursors of migraine according to revised IHS criteria) • Cyclic

Childhood periodic syndromes ( precursors of migraine according to revised IHS criteria) • Cyclic vomiting syndrome. • Abdominal migraine. • Benign paroxismal vertigo of childhood.

Retinal migraine (ocular migraine) • Sudden loss of vision, perception of bright light •

Retinal migraine (ocular migraine) • Sudden loss of vision, perception of bright light • • • followed within one hour by a migrainous headache. Reversible neurologic symptoms. Permanent visual loss may occur. Visual symptoms may occur without headache.

Complications of migraine • Chronic migraine • Status migrainosus (> 72 h) • Persistent

Complications of migraine • Chronic migraine • Status migrainosus (> 72 h) • Persistent aura without infarction • Migrainous infarction • Migraine-triggered seizure.

Migraine variants • Alice in wonderland syndrome • Confusional migraine • Hemisyndrome migraine •

Migraine variants • Alice in wonderland syndrome • Confusional migraine • Hemisyndrome migraine • Menstrual migraine • Ophthalmoplegic migraine

Approach to the child with recurrent headache • History • Physical examination • Laboratory

Approach to the child with recurrent headache • History • Physical examination • Laboratory or imaging studies

When to perform neuroimaging study ? ? • Age < 3 y • Abnormal

When to perform neuroimaging study ? ? • Age < 3 y • Abnormal neurological exam • Chronic progressive pattern • Family reassurance

MRI Vs CT There was no sufficient data to make a specific recommendation regarding

MRI Vs CT There was no sufficient data to make a specific recommendation regarding the relative sensitivity of MRI compared with CT. Most prefer MRI because of vascular differential diagnosis.

EEG and migraine • EEG is not indicated in the routine evaluation of •

EEG and migraine • EEG is not indicated in the routine evaluation of • • headache It is performed if seizures are suspected. EEG findings in children with migraine: -Rolandic spike and wave -Benign focal epileptiform discharges

Management of migraine • Non-pharmacologic methods (biofeedback, relaxation, exercise) • Pharmacologic therapy for acute

Management of migraine • Non-pharmacologic methods (biofeedback, relaxation, exercise) • Pharmacologic therapy for acute attack • Preventive therapy

Pharmacologic Treatment • General pain medications • • • (acetaminophen, NSAIDS) alone or in

Pharmacologic Treatment • General pain medications • • • (acetaminophen, NSAIDS) alone or in combination with antiemetic medications (migraleve) Vasoconstrictors ergot alkaloids/xanthine (cafergot, tamigran) Triptans-5 HT 1 D agonists (imitrex, zomig) Migraine status (> 72 h in adults) - steroids, DHE dihydroergotamin

Triptans • • 5 HT 1 (hydroxytriptamin) receptor agonist Promote vasoconstriction Block pain pathway

Triptans • • 5 HT 1 (hydroxytriptamin) receptor agonist Promote vasoconstriction Block pain pathway in the brain stem Overall efficacy 63 -88% Efficacy and safety were established in adolescents (>12 y) Approved for use in Israel from 18 y Side effects: feeling of warmth, burning, pressure in the head and neck, palpitations, arrythmias, hypotension <1%. C. I: complicated migraine.

American academy of pediatrics october 9 2006 Symptomatic treatment of migraine in children: a

American academy of pediatrics october 9 2006 Symptomatic treatment of migraine in children: a systematic review of medication trials

Conclusion: Acetaminophen, ibuprofen, and nasal, spray sumatryptan are all effective symptomatic pharmacologic treatments for

Conclusion: Acetaminophen, ibuprofen, and nasal, spray sumatryptan are all effective symptomatic pharmacologic treatments for episodes of migraine in children.

Indications for migraine prophylaxis • Attacks occur >2 -4 times per month • Disability

Indications for migraine prophylaxis • Attacks occur >2 -4 times per month • Disability occurs > 3 days per month • Duration of attack > 48 h • Medications for acute attack are ineffective, C. I • • or overused Attacks produce prolonged aura or true migrainous infarction Patient preference

Duration of prophylactic therapy • The optimum duration of prophylactic therapy is • •

Duration of prophylactic therapy • The optimum duration of prophylactic therapy is • • uncertain The approach is to treat for 6 -12 months and then taper over the course of several weeks. Data are limited on the effectiveness of preventive agents in children

Preventive Therapy • B blockers • Antideppressants • Anticonvulsants • Ca channel blocker

Preventive Therapy • B blockers • Antideppressants • Anticonvulsants • Ca channel blocker

B blocker • Propranolol was the prophylactic treatment most • • commonly used in

B blocker • Propranolol was the prophylactic treatment most • • commonly used in children, primarily based upon evidence in adults. C. I: asthma Caution: depression, diabetes, orthostatic hypotension, impotense